INLIF LIMITED Reports First Half of Fiscal Year 2026 Financial Results

INLIF LIMITED (Nasdaq: INLF) reported its first half of fiscal year 2026 results, showing a 26.01% revenue increase to $12.94 million and a net income of $1.01 million, compared to a net loss of $1.98 million in the same period last year. The company's gross profit grew by 158.77% to $4.65 million, with a gross profit margin of 35.95%. The growth was driven by increased sales of manipulator arms and the launch of an intelligent equipment business, which generated $3.36 million in revenue.

Original reporting
Published Sep 24, 2026, 9:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 24, 2026, 9:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$INLF
Bullish
high confidence
Mentioned
$INLF
Relevance
6/10
AlphAI data visualization · based on prnewswire.com
Decision brief

The 30-second read

$INLFBullishMed
01

Why it matters

The earnings release provides the first public disclosure of a profit swing and new product revenue, offering a fresh catalyst for the stock.

02

Market read

Micro‑cap earnings with strong margin expansion may trigger short‑term buying interest, though scale limits broader market impact.

03

What to watch

Potential dilution from the recent PIPE and ATM offering could pressure the stock.

Relevance 6/10Novelty 7/10Timing: after‑hours release

Background

INLIF Limited is a Nasdaq‑listed supplier of manipulator arms for injection molding machines, expanding into intelligent equipment.

Company-level read

Ticker impact

$INLFBullishHigh confidence
Context

INLIF Limited reported unaudited H1 FY2026 results showing revenue up 26% and a swing to $1.01M net income.

Expected impact

Potential modest price rise on post‑earnings momentum.

Evidence & confidence

Revenue growth and profitability reversal are new material facts for a micro‑cap, prompting traders to consider buying on dip.

Market effects

Highlights growing demand for intelligent equipment in new‑energy sector, may benefit peers in industrial automation.

Positive for Chinese‑based manufacturing exporters.

Limited to niche industrial robotics space.

Counterpoint

The revenue base remains small; growth may not be sustainable without larger contracts.

Key entities

  • INLIF Limited

    Nasdaq‑listed manufacturer of industrial robotics and manipulator arms.

Related articles

$INLFMed

INLIF Ltd (INLF): Financial results for H1 2026

INLIF Ltd (INLF) furnished an SEC Form 6-K — earnings release. Exhibit 99.3 INLIF LIMITED Reports First Half of Fiscal Year 2026 Financial Results Quanzhou, China, September 24, 2026 /PRNewswire/ -- INLIF LIMITED (Nasdaq: INLF) (together with all its subsidiaries and consolidated entities, the “Company” or “INLIF”), a company engaged in the

$INLFMedAI 8/10

INLIF LIMITED Accelerates Strategic Layout in New Energy Sector, Securing $4.4 Million First Order for Battery Cell Packing Machines

INLIF Limited (NASDAQ: INLF) said it confirmed commercial delivery of its first battery cell packing machines order, worth nearly RMB 30 million (about US$4.4 million). The contract includes 14 units for a domestic battery manufacturer; the customer also placed a follow-on order for six more units. INLIF estimates up to 50 units by end-2026 (about RMB 100 million+), subject to demand and execution risks.

$AVLNMed

Avalyn Reports Third Quarter 2026 Financial Results and Recent

Avalyn Pharma Inc. (AVLN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Avalyn Reports Third Quarter 2026 Financial Results and Recent Business Highlights Initiated Phase 1 study of AP03, a fixed dose combination of nebulized pirfenidone and nintedanib, in healthy volunteers Presented new AP01 data at ERS Congress and published detailed results from

$MGTXHigh

MeiraGTx Reports Third Quarter 2026 Financial and Operational Results

MeiraGTx Holdings plc (MGTX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 MeiraGTx Reports Third Quarter 2026 Financial and Operational Results ● Submission of Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for botaretigene sparoparvovec (bota-vec) for the treatment of X-linked retinitis pigmentosa (XLRP)

$VOXRMed

VOX ROYALTY CORP. (VOXR): Financial results for Q3 2026

VOX ROYALTY CORP. (VOXR) furnished an SEC Form 6-K — earnings release. EXHIBIT 99.5 VOX ROYALTY REPORTS Q3 2026 RESULTS AND DECLARES QUARTERLY DIVIDEND DENVER – November 11, 2026 – Vox Royalty Corp. (NASDAQ: VOXR ) (TSX: VOXR ) (“ Vox ” or the “ Company ”), a returns-focused mining royalty and streaming company, is pleased to announce its operating

$LUCDMed

Lucid Diagnostics Provides Business Update and Reports Third Quarter 2026 Financial Results

Lucid Diagnostics Inc. (LUCD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Lucid Diagnostics Provides Business Update and Reports Third Quarter 2026 Financial Results EsoGuard ® now fully reimbursed by Medicare nationwide, launching a new phase of accelerating commercialization with record monthly test volume to start the fourth quarter Con